496054-85-4 Usage
Uses
Used in Pharmaceutical Synthesis:
[4-(4-Fluorobenzyl)piperidin-1-yl](oxo)acetic acid is used as a potential intermediate in the synthesis of pharmaceutical compounds due to its unique chemical structure, which may facilitate the development of new drugs with specific therapeutic properties.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, [4-(4-Fluorobenzyl)piperidin-1-yl](oxo)acetic acid is used as a compound with potential biological activity. Its structure, featuring a piperidine ring and a fluorobenzyl group, suggests that it may act as a ligand for certain receptors or enzymes, making it a candidate for further investigation in drug discovery and development.
Used in Drug Discovery:
[4-(4-Fluorobenzyl)piperidin-1-yl](oxo)acetic acid is utilized in drug discovery as a compound with potential applications in the development of new therapeutic agents. Its unique structure may allow for the creation of drugs that target specific biological pathways or interact with particular receptors, contributing to the advancement of novel treatment options.
Used in Chemical Research:
In the realm of chemical research, [4-(4-Fluorobenzyl)piperidin-1-yl](oxo)acetic acid serves as a subject of study to better understand its chemical properties and potential reactivity with other compounds. This knowledge can be applied to optimize its synthesis and explore its possible applications in various chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 496054-85-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,9,6,0,5 and 4 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 496054-85:
(8*4)+(7*9)+(6*6)+(5*0)+(4*5)+(3*4)+(2*8)+(1*5)=184
184 % 10 = 4
So 496054-85-4 is a valid CAS Registry Number.
496054-85-4Relevant academic research and scientific papers
Oxamides as novel NR2B selective NMDA receptor antagonists
Barta-Szalai, Gizella,Borza, Istvan,Bozo, Eva,Kiss, Csilla,Agai, Bela,Proszenyak, Agnes,Keseru, Gyoergy M.,Gere, Aniko,Kolok, Sandor,Galgoczy, Kornel,Horvath, Csilla,Farkas, Sandor,Domany, Gyoergy
, p. 3953 - 3956 (2007/10/03)
A novel series of oxamides derived from indole-2-carboxamides was identified as potent NR2B selective NMDA receptor antagonists. Several members of this group showed good analgesic activity in the mouse formalin test.
